|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening. |
| 公司地址
| 5505 Endeavor Lane, Madison, WI, USA, 53719 |
| 電話號碼
| +1 608 284-5700 |
| 傳真號碼
| +1 608 284-5701 |
| 公司網頁
| https://www.exactsciences.com |
| 員工數量
| 7200 |
| Mr. Aaron Bloomer |
Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 431.87K |
13/02/2026 |
| Mr. James Herriott |
Senior Vice President, General Counsel and Secretary |
-- |
13/02/2026 |
| Mr. Kevin T. Conroy |
Chairman of the Board, President and Chief Executive Officer |
美元 1.08M |
13/02/2026 |
| Mr. Jacob Orville |
Executive Vice President and General Manager, Screening |
美元 618.00K |
13/02/2026 |
| Ms. Sarah Condella |
Executive Vice President, Human Resources |
美元 509.00K |
13/02/2026 |
| Mr. Brian Baranick |
Executive Vice President and General Manager, Precision Oncology |
美元 600.40K |
13/02/2026 |
|
|
| Mr. Michael J. Barber |
Independent Director |
13/02/2026 |
| Mr. D. Scott Coward |
Director |
13/02/2026 |
| Mr. James E. Doyle |
Lead Independent Director |
13/02/2026 |
| Ms. Katherine S. Zanotti |
Independent Director |
13/02/2026 |
| Ms. Leslie L. Trigg |
Independent Director |
13/02/2026 |
| Ms. Kimberly J. Popovits |
Independent Director |
13/02/2026 |
| Ms. Shacey Petrovic |
Independent Director |
13/02/2026 |
| Mr. Kevin T. Conroy |
Chairman of the Board, President and Chief Executive Officer |
13/02/2026 |
| Mr. Paul J. Clancy, M.B.A. |
Independent Director |
13/02/2026 |
|
|
|
|
